The experience with Covid vaccine development has provided India a unique opportunity to burnish its credentials as a global leader in the discovery of new drugs and medicines, and as a manufacturing base for the global market. To build on this foundation, the sector needs a clear policy roadmap that is supportive of innovative development of drug research. Public funding can be an important catalyst.
